Cocrystal Pharma's total assets for Q3 2025 were $10.45M, an increase of 22.82% from the previous quarter. COCP total liabilities were $2.78M for the fiscal quarter, a -12.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.